reference/33139600

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33139600

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	692
issn	1001-0602 1748-7838
issueIdentifier	8
pageRange	678-692
publicationName	Cell Research
startingPage	678
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ee1e037b0c1a458646e0730cb1405f8b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_91bec3d7b8146e1e76199e69dbf3f674 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_674d14a0a14589dc68f70b4012bb2f1b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6fbd7fd02c0b0198233d2001a95ad474 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6c5e820479a719793af3ef540ae0c633
bibliographicCitation	Ma C, Sacco MD, Hurst B, Townsend JA, Hu Y, Szeto T, Zhang X, Tarbet B, Marty MT, Chen Y, Wang J. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Research. 2020 Jun 15;30(8):678–92. doi: 10.1038/s41422-020-0356-z.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5766-8189 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_928629acb883470e410baa71d9767815 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2a509fe3b58074911c1ac69c8bf09d7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0525-7342 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d46ace6d871b2201215cca1e8b30f0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_435b12a25b08209cc539062966d051a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4845-4621 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e80539dc06f179b0f7ad8ac65053c41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ce3af99282062d0e62d1a7922479eff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c602143ede71e96e07b95c97726e19c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62add54d357207d1ed266761b659968e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64a86f6f801613124b1a7a3a102d8d80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2e5ff3d8a4a3945a0dbf2d51595c1cb
date	2020-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/s41422-020-0356-z https://pubmed.ncbi.nlm.nih.gov/PMC7294525 https://pubmed.ncbi.nlm.nih.gov/32541865
isPartOf	https://portal.issn.org/resource/ISSN/1001-0602 https://portal.issn.org/resource/ISSN/1748-7838 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20515
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
discusses	http://id.nlm.nih.gov/mesh/M0026358 http://id.nlm.nih.gov/mesh/M000744326 http://id.nlm.nih.gov/mesh/M0009493 http://id.nlm.nih.gov/mesh/M0500464 http://id.nlm.nih.gov/mesh/M000733006 http://id.nlm.nih.gov/mesh/M0005542 http://id.nlm.nih.gov/mesh/M0117753 http://id.nlm.nih.gov/mesh/M0018277 http://id.nlm.nih.gov/mesh/M0020792 http://id.nlm.nih.gov/mesh/M0017693 http://id.nlm.nih.gov/mesh/M0001518
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10324367 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71481119 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917049

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405560324 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID252166817 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442878666 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442878669 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223366205

Total number of triples: 63.